Status:
COMPLETED
Intra-operative Visual Examination at IDS
Lead Sponsor:
Catholic University of the Sacred Heart
Conditions:
Diaphragm Disease
Eligibility:
FEMALE
Brief Summary
Complete disease removal has the greatest impact in the treatment of advanced ovarian cancer, both during primary debulking surgery (PDS) and interval debulking surgery (IDS), but, contrarily to PDS, ...
Detailed Description
All data of patients subjected to IDS between October 2016 and October 2019 with evidence of suspected or certain residual disease at the level of the right diaphragmatic peritoneum, at intra-operativ...
Eligibility Criteria
Inclusion
- patients with histology proven biopsy of epithelial ovarian, fallopian or peritoneal cancer (FIGO stage III C - IV B), judged suitable for IDS by clinicians, with evidence of suspected or certain residual disease at the level of the right diaphragmatic peritoneum, at intraoperative evaluation.
Exclusion
- Patients with no evidence of diaphragmatic disease during IDS, and who therefore did not undergo diaphragmatic peritonectomy or biopsy
Key Trial Info
Start Date :
October 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2019
Estimated Enrollment :
155 Patients enrolled
Trial Details
Trial ID
NCT04444934
Start Date
October 1 2016
End Date
December 1 2019
Last Update
July 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Universitario A. Gemelli, IRCCS
Rome, RM, Italy, 00168